Experiment summary for ENCSR000EEO
doi:10.17989/ENCSR000EEO
Summary
- Status
- released
- Assay
- ChIP-seq (TF ChIP-seq)
- Target
- SREBF1
- Biosample summary
- Homo sapiens HepG2 treated with 10 μM 22-hydroxycholesterol for 6 hours, 100 nM insulin for 6 hours
- Biosample Type
- cell line
- Replication type
- isogenic
- Description
- SREBF1 ChIP-seq on human HepG2 treated with insulin
- Treatments
- 10 μM 22-hydroxycholesterol for 6 hours, 100 nM insulin (UniProtKB:P01308) for 6 hours
- Nucleic acid type
- DNA
- Fragmentation methods
- see document
- Platform
- Illumina Genome Analyzer
- Controls
Attribution
ENCODE2 project
- Lab
- Michael Snyder, Stanford
- Award
- U54HG004558 (Michael Snyder, Stanford)
- Project
- ENCODE
- External resources
- Date submitted
- October 29, 2011
- Date released
- October 29, 2011
- Annotation (gkmsvm-model)
- Factorbook
Encyclopedia Integration
Isogenic replicates
Isogenic replicate | Technical replicate | Summary | Biosample | Antibody | Library |
---|---|---|---|---|---|
3 | 1 | Homo sapiens HepG2 cell line treated with 10 μM 22-hydroxycholesterol for 6 hours, 100 nM insulin for 6 hours | ENCBS849AAA | ENCAB000ALC | ENCLB209AHI |
1 | 1 | Homo sapiens HepG2 cell line treated with 10 μM 22-hydroxycholesterol for 6 hours, 100 nM insulin for 6 hours | ENCBS849AAA | ENCAB000ALC | ENCLB209AJB |
2 | 1 | Homo sapiens HepG2 cell line treated with 10 μM 22-hydroxycholesterol for 6 hours, 100 nM insulin for 6 hours | ENCBS849AAA | ENCAB000ALC | ENCLB209AJC |